Vladimir Muzykantov (MD from First Moscow Medical School, 1980 and Ph.D. in Biochemistry from Russian National Cardiology Research Center, 1985), joined PENN in 1993 and in 2010 became a Professor and Vice-Chair of the Department of Systems Pharmacology and Translational Therapeutics. He established and since 2010 directs the Center for Targeted Therapeutics and Translational Nanomedicine. He published >200 papers and edited a book “Biomedical Aspects of Drug Targeting” (Kluwer, 2003). Honors include Established Investigator (1996) and Bugher Stroke (2000) Awards from the American Heart Association, the Keynote and Chairing forums including Transatlantic Airway Conference on Targeting Molecular Signatures in Lungs (Luzerne, 2009), Gordon Conference on Drug Carriers (2012) and HLBI Division of Lung Diseases Workshop “Precision Therapeutics Delivery for Lung Diseases” (2014), Annual Italian Society of Biochemistry and Molecular Biology Conference (2015). His research focuses on drug delivery by red blood cells and endothelial targeting for treatment inflammation, thrombosis and ischemia.